December 4, 2020: Todos Medical reports $3.2M in sales month of Nov + 3CL Protease in development

03 1055 Session 2 Immunology 002Подробнее

Harnessing the benefits of CD34+ cells collected for double HSCT in patients with multiple myelomaПодробнее

Day 1, October 4, 2012: SESSION III, Part 2Подробнее

SCID Education Session: Post-Transplant Late Effects in Patients with SCIDПодробнее

New treatment strategies for multiple myelomaПодробнее

Digital Infoday Session - Managing myeloma: the long-term effectsПодробнее

3D visualisation technology for biopsies: Nominated for the Spark AwardПодробнее

Updated Efficacy and Safety Results of the Phase 3 CANDOR studyПодробнее

Debate: Optimal Maintenance Therapy Duration - Maintenance for 2yrsПодробнее

3-month Progress Report of the SU Centre for Translational MedicineПодробнее

Third Congress, 4-Scientific Session Two （Panel Discussion）& ClosingПодробнее

After Grand Rounds Post show 4 22 20Подробнее

Optimizing the outcomes of autoHSCT in multiple myelomaПодробнее

Results from a Phase I study of CC-98633 in R/R myelomaПодробнее

ESH 3rd How to Diagnose and Treat Multiple Myeloma: virtual tour of the E-Conference platformПодробнее

The benefits of CAR-T therapy in 2L over 3L in R/R DLBCLПодробнее

Updates in Multiple Myeloma Research - 2018Подробнее

ASH Annual Meeting: CAR-T and Multiple MyelomaПодробнее